人工智能有潜力加速治疗罕见疾病的药物开发
Giulio Napolitano1, Canan Has2, Anne Schwerk3
1Centogene GmbH, Alboinstraße 36-42, 12103, Berlin, Germany. gnapolitano01@qub.ac.uk.
Pharmaceutical medicine
|February 5, 2024
概括
人工智能 (AI) 通过整合数据,加速治疗罕见疾病的药物开发,尽管面临挑战. 人工智能是一个有价值的工具,支持而不是取代药物研究中的人类专业知识.
科学领域:
- 生物医学研究的研究.
- 计算生物学是一种计算生物学.
- 药物发现 药物发现
背景情况:
- 随着数字数据的增加,人工智能 (AI) 应用正在迅速扩展.
- 针对罕见疾病的药物开发面临着重大障碍,原因是数据稀缺和高成本.
研究的目的:
- 审查AI在药物开发中的应用,重点关注罕见疾病.
- 突出AI在这个专业领域的成就和挑战.
主要方法:
- 使用人工智能集成异质数据集和知识库.
- 利用专家的生物学理解来指导人工智能方法.
- 分析AI在克服罕见疾病研究数据短缺方面的作用.
主要成果:
- 人工智能通过大规模数据集成,为罕见疾病药物开发提供了新的方法.
- 人工智能有助于使用以前无法访问的复杂生物数据.
- 在保守的制药行业,人工智能在常规采用方面仍然存在挑战.
结论:
- 人工智能是药物发现和开发的强大支持工具,特别是对于罕见疾病.
- 人工智能可以帮助但不能取代人类在制药研发方面的专业知识.
- 解决障碍对于AI在药物开发中的常规实施至关重要.
更多相关视频
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Prescription, Nonprescription and Orphan Drugs
733
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
733
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


